Cargando…
Long-term outcomes of intravitreous bevacizumab or tissue plasminogen activator or vitrectomy for macular edema due to branch retinal vein occlusion
PURPOSE: The purpose of this study was to determine the long-term outcomes of intravitreal bevacizumab (IVB) or intravitreal tissue plasminogen activator (tPA) or vitrectomy for macular edema associated with a branch retinal vein occlusion (BRVO). METHODS: This was a retrospective, interventional ca...
Autores principales: | Kumagai, Kazuyuki, Ogino, Nobuchika, Fukami, Marie, Furukawa, Mariko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6469473/ https://www.ncbi.nlm.nih.gov/pubmed/31043767 http://dx.doi.org/10.2147/OPTH.S195600 |
Ejemplares similares
-
Vitrectomy for macular edema due to retinal vein occlusion
por: Kumagai, Kazuyuki, et al.
Publicado: (2019) -
Effects of Vitrectomy on Recurrent Macular Edema due to Branch Retinal Vein Occlusion after Intravitreal Injection of Bevacizumab
por: Yunoki, Tatsuya, et al.
Publicado: (2013) -
Intravitreal bevacizumab for macular edema due to branch retinal vein occlusion: 12-month results
por: Demir, Mehmet, et al.
Publicado: (2011) -
Intravitreal bevacizumab in macular edema secondary to branch retinal vein occlusion: 12-month results
por: Thapa, Raba, et al.
Publicado: (2012) -
Comparison Between Intravitreal Bevacizumab and Triamcinolone for Macular Edema Secondary to Branch Retinal Vein Occlusion
por: Kim, Jin Young, et al.
Publicado: (2009)